Document Detail


Possible association of benzalkonium chloride in nebulizer solutions with respiratory arrest.
MedLine Citation:
PMID:  1611157     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To report a case of possible association of benzalkonium chloride in nebulizer solutions with respiratory arrest and to review the involvement of various preservative agents in paradoxical bronchoconstrictive reactions. DATA SOURCES: Reference articles, case reports, and editorials are identified in the text. DATA SYNTHESIS: Many pharmacologic agents are available for nebulization. In addition to the active drug, these nebulizer solutions may contain preservatives. We describe a case of respiratory arrest in a 64-year-old man following nebulization therapy with albuterol and ipratropium solutions. These solutions contain benzalkonium chloride as a preservative. We are aware of only one report describing two deaths associated with such a severe reaction attributable to nebulization therapy. However, many reports of milder paradoxical bronchoconstriction are available in the medical literature. CONCLUSIONS: Clinicians should be aware of the possibility of paradoxical bronchoconstrictive reactions when patients are treated with nebulized bronchodilators.
Authors:
M Boucher; M T Roy; J Henderson
Related Documents :
17343617 - Contact allergy epidemics and their controls.
3569037 - Hypersensitivity reaction following chloramphenicol administration in a patient with ty...
20971677 - Ocular surface disease: a case of vernal keratoconjunctivitis.
12777457 - Severe systemic reaction to (99m)tc-methylene diphosphonate: a case report.
24890567 - An update on the incidence of dengue gaining strength in saudi arabia and current contr...
21404357 - Retrospective review of diagnostic performance of intracranial translucency in the dete...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  26     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  1992 Jun 
Date Detail:
Created Date:  1992-07-29     Completed Date:  1992-07-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  772-4     Citation Subset:  IM    
Affiliation:
Pulmonary and Internal Medicine, Ottawa General Hospital, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Benzalkonium Compounds / adverse effects*
Humans
Male
Middle Aged
Nebulizers and Vaporizers
Respiratory Insufficiency / chemically induced*
Solutions / standards
Chemical
Reg. No./Substance:
0/Benzalkonium Compounds; 0/Solutions

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular...
Next Document:  Loss of seizure control associated with generic substitution of carbamazepine.